Skip to main content
. 2019 Oct;38(5):2071–2078. doi: 10.1016/j.clnu.2018.09.025

Table 2.

Muscle mRNA expression.

Groups BASAL
2 week
4 week
6 week
Rest Acute RET Rest Acute RET Rest Acute RET Rest Acute RET
cMyc
5′-GGTAGTGGAAAACCAGCAGCC-3′ PLA 1.0 ± 0.7 3.0 ± 2.0* 1.0 ± 0.6 4.9 ± 0.7* 0.6 ± 0.4 3.0 ± 3.3* 1.2 ± 1.3 2.2 ± 1.0
5′-TCTCCTCCTCGTCGCAGTA-3′ HMB 0.9 ± 0.6 3.0 ± 1.9* 1.9 ± 3.8 3.0 ± 1.9* 0.6 ± 0.3 2.6 ± 1.7* 1.5 ± 2.2 1.7 ± 2.0
Myostatin
5′-GCTGCGCCTGGAAACAGCTC-3′ PLA 1.0 ± 0.3 1.1 ± 0.6 1.7 ± 1.3 1.0 ± 0.4 1.1 ± 0.5 0.8 ± 0.3 1.0 ± 0.6 1.4 ± 0.8
5′-ATCAGTTCCCGGAGTGGAGGC-3′ HMB 1.3 ± 0.7 1.1 ± 0.5 1.6 ± 0.8 0.8 ± 0.3 1.1 ± 0.6 1.0 ± 0.7 0.9 ± 0.5 1.1 ± 0.4
Myogenin
5′-ACCCTACAGATGCCCACAAC-3′ PLA 1.0 ± 0.4 0.7 ± 0.4 1.1 ± 0.9 0.7 ± 0.2 0.4 ± 0.3 0.9 ± 0.8 1.0 ± 0.6 0.9 ± 0.6
5′-GGAAGGCCACAGACACATCT-3′ HMB 0.5 ± 0.2 1.0 ± 0.5 0.5 ± 0.3 0.7 ± 0.4 1.3 ± 0.9 0.5 ± 0.2 1.2 ± 1.5 0.6 ± 0.3
MyoD
5′-CTCCGACGGCATGATGGACTA-3′ PLA 1.0 ± 0.6 0.8 ± 0.4 1.3 ± 0.5 0.8 ± 0.6 0.5 ± 0.4 0.5 ± 0.3 0.6 ± 0.3 0.9 ± 0.5
5′-TGGGCGCCTCGTTGTAGTA-3′ HMB 2.5 ± 1.5 1.9 ± 1.1 3.3 ± 1.3 2.1 ± 1.6 1.1 ± 1.0 1.2 ± 0.7 1.6 ± 0.7 1.3 ± 1.3
Myf5
5′-ATGCCCGAATGTAACAGTCCT-3′ PLA 1.0 ± 0.5 1.0 ± 0.5 0.7 ± 0.3 0.7 ± 0.4 0.3 ± 0.2 0.6 ± 0.4 0.7 ± 0.3 1.0 ± 0.6
5′-GGTTGCTCTGAGGAGGTGAT-3′ HMB 0.9 ± 0.8 0.5 ± 0.5 0.8 ± 0.9 0.7 ± 0.6 0.5 ± 0.3 0.6 ± 0.3 0.6 ± 0.4 0.7 ± 0.4
eIF3f
5′-GTTGGGAACTGTCGACAAAC-3′ PLA 1.0 ± 0.5 0.9 ± 0.3 0.7 ± 0.2 1.0 ± 0.7 0.5 ± 0.3 0.6 ± 0.2 0.6 ± 0.2 0.9 ± 0.5
5′-ATTCCATGTCAACAGCCACT-3′ HMB 0.8 ± 0.4 0.7 ± 0.3 0.7 ± 0.2 0.7 ± 0.5 0.5 ± 0.2 0.6 ± 0.3 0.6 ± 0.1 0.5 ± 0.1
REDD1
5′-AAGACACGGCTTACCTGGA-3′ PLA 1.0 ± 0.6 1.0 ± 0.6 0.8 ± 0.4 0.5 ± 0.2 0.4 ± 0.2 0.6 ± 0.5 0.8 ± 0.4 1.0 ± 0.9
5′-CAGTAGTTCTTTGCCCACCT-3′ HMB 0.9 ± 0.6 0.9 ± 0.6 0.6 ± 0.3 0.7 ± 0.4 0.5 ± 0.3 1.1 ± 0.8 0.8 ± 0.4 0.4 ± 0.1
MURF1
5′-AGTGACCAAGGAGAACAGTCA-3′ PLA 1.0 ± 1.2 2.3 ± 1.6 0.6 ± 0.3 1.5 ± 1.6 0.4 ± 0.3 0.6 ± 0.4 0.5 ± 0.4 0.6 ± 0.4
5′-CACCAGCTTTGTGGACTTGT-3′ HMB 0.4 ± 0.2 0.8 ± 0.4 0.3 ± 0.2 0.7 ± 0.6 0.2 ± 0.1 0.6 ± 0.4 0.4 ± 0.2 0.4 ± 0.2
MAFbx
5′-CCTTCACTGACCTGCCTTT-3′ PLA 1.0 ± 0.5 1.8 ± 1 0.8 ± 0.5 0.7 ± 0.7 0.7 ± 0.9 0.6 ± 0.3 0.4 ± 0.2 0.7 ± 0.4
5′-CCTTCACTGACCTGCCTTT-3′ HMB 0.6 ± 0.4 0.5 ± 0.3 0.4 ± 0.2 0.6 ± 0.5 0.3 ± 0.2 0.5 ± 0.4 0.4 ± 0.2 0.3 ± 0.1
Ubiquitin
5′-GATCTGCCGCAAGTGCTA-3′ PLA 1.0 ± 2.0 1.1 ± 1.6 1.1 ± 2.4 1.1 ± 2.4 0.5 ± 1.2 0.6 ± 0.6 0.4 ± 0.6 0.5 ± 0.8
5′-CAGTCAATGAAAGGGACACT-3′ HMB 0.6 ± 1.0 0.4 ± 0.3 0.6 ± 1.2 0.6 ± 1.1 0.5 ± 0.7 0.5 ± 0.7 0.4 ± 0.9 0.3 ± 0.4
Calpain
5′-GCCAAGCAGGTGAAC-3′ PLA 1.0 ± 1.0 0.7 ± 0.4 0.7 ± 0.3 1.2 ± 1.1 0.4 ± 0.3 0.5 ± 0.3 0.5 ± 0.3 0.7 ± 0.5
5′-TGAAGTCTCGGAATGACATC-3′ HMB 0.45 ± 0.3 0.3 ± 0.1 0.4 ± 0.3 0.6 ± 0.4 0.5 ± 0.3 0.3 ± 0.1 0.4 ± 0.2 0.4 ± 0.2

*Significantly different from rest leg at each timepoint and within in each condition P < 0.05.